Medicamen Biotech Ltd


Medicamen Biotech Ltd

Health CarePharmaceuticals and Biotechnology
  • Price (INR)618.00
  • Today's Change0.65 / 0.11%
  • Shares traded14.44k
  • 1 Year change-7.42%
  • Beta--
Data delayed at least 15 minutes, as of Mar 20 2023 09:59 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Medicamen Biotech Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing pharmaceutical formulations products. The Company manufactures a range of products, including tablets, capsules, liquid syrup, dry syrup, such as beta-lactum and non-beta lactum, and ointments. The Company is primarily focused on oncology therapeutics. The Company is also focused on other therapeutic areas, such as cardiology, central nervous system (CNS), diabetology and pain management. The Company's oncology products include Abiraterone acetate, Anastrozole, Bicalutamide, Bendmustine HCL, Bortezomib, Busulfan, Capecitabine, Cisplatin, Erlotinib HCL, Gefitinib, Imatinib mesylate, Lenalidomide, Letrozole, Melphalan, Nilotinib HCI, Oxaliplatin, Pazopanib, Pomalidomide and Tegafur. The Company has two manufacturing plants at Bhiwadi (Rajasthan) and Haridwar (Uttarakhand). The Company's wholly owned subsidiary is OPAL Pharmaceuticals Pty Ltd.

  • Revenue in INR (TTM)1.25bn
  • Net income in INR137.00m
  • Incorporated1993
  • Employees357.00
  • Location
    Medicamen Biotech Ltd1506, Chiranjiv Tower, 43, Nehru PlaceNEW DELHI 110019IndiaIND
  • Phone+91 1 147589500
  • Fax+91 1 126213081
  • Websitehttp://www.medicamen.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Windlas Biotech Ltd4.95bn459.70m5.07bn962.0011.36--8.781.0221.1321.13227.25--------5,140,343.00--------36.09--9.30----50.42----8.96--140.58------
Kopran Ltd5.43bn367.07m5.12bn400.0013.84--10.490.94317.687.68113.36--------13,585,460.00--9.73--15.4536.5236.606.759.40--4.01-----2.918.42-0.933425.1121.27--
SMS Pharmaceuticals Ltd4.34bn-41.61m5.46bn1.03k----14.541.26-0.4871-0.487151.05--------4,205,091.00--7.71--10.2222.9434.081.2510.04---0.227--5.01-7.693.08-0.49116.913.268.45
Syncom Formulations India Ltd2.22bn163.62m5.64bn--29.46--27.192.550.20370.20372.65------------7.84--10.4336.1531.247.398.17--4.10-----10.273.51-32.1613.197.588.45
Beta Drugs Ltd-100.00bn-100.00bn6.06bn--------------------------------------------------57.91--356.78------
Lincoln Pharmaceuticals Ltd5.00bn713.61m6.61bn1.25k9.27--8.251.3235.6235.62249.77------------13.45--17.0852.3750.5514.2613.25--56.07----11.305.2611.4619.7920.914.56
Vimta Labs Ltd3.00bn487.64m6.65bn1.27k13.882.588.772.2121.6521.65133.37116.380.95883.903.892,359,890.0015.568.8818.8211.1876.1771.3416.2310.452.2725.640.063815.8932.0912.5893.0931.30-0.5906--
Medico Remedies Ltd-100.00bn-100.00bn6.68bn----------------------------3.41--7.20--24.67--2.43---------1.1217.3388.6824.60-4.35--
Panacea Biotec Ltd4.72bn12.17bn6.96bn1.06k0.5729--0.56711.48198.47198.4777.11--------4,458,904.00--9.69--17.4643.9855.39257.8524.67---2.27--0.005.833.46837.06---12.14--
Zota Health Care Ltd1.34bn-41.49m7.47bn297.00----135.595.56-1.65-1.6553.61--------4,526,751.00--5.37--7.0536.4830.73-3.094.88---1.62--67.6322.8512.884,364.059.9611.070.9805
Jagsonpal Pharmaceuticals Ltd2.25bn204.13m7.80bn--38.24--35.833.477.797.7985.90------------5.39--6.8560.3658.229.084.60--98.92--38.8515.778.4410.549.71-28.93109.13
Medicamen Biotech Ltd1.25bn137.00m7.81bn357.0056.06--39.106.2511.0111.01100.53--------3,500,164.00--8.02--11.9751.2233.6610.9710.62--6.12--9.012.426.9622.8223.6229.990.00
Bliss GVS Pharma Ltd7.34bn871.47m7.83bn750.009.15--6.821.078.218.2169.11--------9,784,959.00--7.11--9.8748.3136.8713.1810.68--16.38--11.7929.5012.91-78.04-6.36-6.52-3.58
NGL Fine-Chem Ltd2.82bn-817.29m8.26bn329.00------2.93-132.29-132.29457.23--------8,580,666.00--17.96--24.1813.7748.76-28.9514.83---63.53--2.9323.0824.42-12.0327.3722.93--
Bajaj Healthcare Ltd6.91bn569.04m9.11bn1.05k16.02--11.241.3220.6220.62250.20--------6,564,269.00--11.38--19.7026.4725.658.248.64--4.44----3.4924.14-14.1155.6150.96--
Data as of Mar 20 2023. Currency figures normalised to Medicamen Biotech Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
Motilal Oswal Asset Management Co. Ltd.as of 28 Feb 202352.000.00%
Data from 28 Feb 2023 - 28 Feb 2023Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.